🇺🇸 FDA
Patent

US 11358991

Heme sequesting peptides and uses therefor

granted A61KA61K38/00A61K38/164

Quick answer

US patent 11358991 (Heme sequesting peptides and uses therefor) held by The Board of Regents of the University of Texas System expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K38/00, A61K38/164, A61K45/06, A61P